Real-time global intelligence

© 2026 OpenWatch. All rights reserved.

For informational and entertainment purposes only. Not investment advice.

Platform

Brief
Signals
Countries
Companies
Industries
Themes
Scenarios
Rankings

Tools

Globe
Analytics
Crises
Clusters
Supply Chain
Alliances
Screener
Watchlist
Portfolio

Developer

API Reference
Developer Keys
Webhooks
Status

Sources

View all sources →

1,000+ tracked sources

Signals updated every 15 minutes

Not investment advice. OpenWatch is provided for informational and entertainment purposes only. While we strive for accuracy, precision, and source attribution in all intelligence assessments, geopolitical analysis involves inherent uncertainty and our conclusions may be incomplete, delayed, or incorrect. Nothing on this platform constitutes financial, investment, legal, or professional advice of any kind. Forward-looking scenarios and probability estimates are analytical hypotheses — not independently validated forecasts. Any actions taken based on information found here are solely your responsibility. Always consult a qualified financial advisor before making investment decisions. Past signal patterns do not guarantee future outcomes.

Methodology
Privacy Policy
Terms of Use

openwatch.io

v·a6d9660

Entity Search

Look up signals and intelligence for any entity

Entity Intelligence

Novo Nordisk's

14 signals · last 30dPolitical

30d signal volume

By Threat Layer

1

1

Top Signals

View all signals →

PoliticalUpdate21d ago

Novo Nordisk rejected Eli Lilly [5 sources]

6.5

PoliticalUpdate22d ago

Novo Nordisk rejected in United Kingdom [10 sources]

6.5

🇬🇧

GB

PoliticalUpdate21d ago

Canada criticized Novo Nordisk in Toronto [16 sources]

5.8

PoliticalUpdate22d ago

Canada criticized Novo Nordisk in Toronto [8 sources]

5.8

PoliticalUpdate22d ago

Manufacturer criticized Novo Nordisk in Pennsylvania [5 sources]

5.8

PoliticalUpdate24d ago

Ireland criticized Novo Nordisk in Canada [8 sources]

5.8

PoliticalUpdate24d ago

Canada criticized Novo Nordisk in India [6 sources]

5.8

PoliticalUpdate24d ago

Canada criticized Novo Nordisk in Canada [4 sources]

5.8

PoliticalUpdate25d ago

Canada criticized Novo Nordisk in India [6 sources]

5.8

PoliticalUpdate25d ago

Canada criticized Novo Nordisk in Toronto [6 sources]

5.8

PoliticalUpdate25d ago

Toronto criticized Novo Nordisk in Toronto [8 sources]

5.8

CriminalUpdate16d ago

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.

3.1

Supply ChainUpdate18d ago

Novo Nordisk’s head start on GLP-1 pills forces investors to rethink Eli Lilly's dominance Early signs from the launch of Novo Nordisk's Wegovy pill and Eli Lilly & Co.'s Foundayo are making investors rethink the opportunity for GLP-1 pills.

3.1

EconomicUpdate23d ago

Eli Lilly's weight loss pill launch has been closely watched after the successful start of Novo Nordisk's Wegovy pill. This represents standard competitive activity in the pharmaceutical market for obesity treatments.

2.5

View all signals for "Novo Nordisk's" →

Co-mentioned With

8

5

🏛️Novo Nordisk

3

2

🏛️Eli Lilly's

2

📍United Kingdom

1

🏛️Manufacturer

1

📍Pennsylvania

1

1

🏛️Novo Nordisk’s

Top Countries

6 🇺🇸United States

3 🇮🇳India

2 🇬🇧United Kingdom

Related Themes

🧠AI Chip BottleneckOPP 🚢Red Sea EscalationRISK ⚓Shipping Lane FragmentationRISK

Explore

→ Signal search → Signal feed → Map view → API (JSON)→ RSS Feed